Upcoming events

All Events
Find News

I-MED Pharma Launches tearcheck® in Canada 2020-11-11

I-MED Pharma announced the launch of tearcheck®, a new Health Canada approved diagnostic and analyzing tool that performs nine exams in under 10 minutes.


With a significant percentage of the population experiencing the pain and discomfort of dry eye symptoms and that number being on the rise, it is more important than ever to have a sophisticated diagnostic tool that can help eye care professionals quickly and easily screen patients for dry eye and provide reliable diagnostic data to determine the cause of their symptoms. 


The tearcheck® was designed and developed by the French manufacturer E-Swin and offers the newest technological advancements to simplify dry eye diagnosis. The tearcheck® is a fully automatic screening device that has easy to read metrics that provide a visual explanation of patients’ signs and symptoms of dry eye and has a user interface that is intuitive, quick, and easy to use. Combining all the latest evaluation standards for dry eye, tearcheck® can perform nine examinations in one breakthrough device.


Daniel Hofmann, President of I-MED Pharma stated, “tearcheck® is a fully functional, stand-alone device that is designed specifically for dry eye analysis. It is the perfect complementary device to our dry eye management and treatment product line, and we are proud to be the exclusive Canadian distributor who brings this innovative product to the Canadian eye care community.”

MIDO 2021 Skyscraper EN
Digital ECP Private EN